These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 28878093

  • 1. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C, Dalton GN, Farré PL, De Luca P, De Siervi A.
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [Abstract] [Full Text] [Related]

  • 2. miRNAs as novel biomarkers in the management of prostate cancer.
    Filella X, Foj L.
    Clin Chem Lab Med; 2017 May 01; 55(5):715-736. PubMed ID: 26751899
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B, Lupold SE.
    Asian J Androl; 2016 May 01; 18(4):559-67. PubMed ID: 27056344
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
    Jia L, Gui B, Zheng D, Decker KF, Tinay I, Tan M, Wang X, Kibel AS.
    Prostate; 2017 Jun 01; 77(9):1000-1011. PubMed ID: 28422308
    [Abstract] [Full Text] [Related]

  • 9. The role of microRNAs in prostate cancer migration, invasion, and metastasis.
    Aghdam SG, Ebrazeh M, Hemmatzadeh M, Seyfizadeh N, Shabgah AG, Azizi G, Ebrahimi N, Babaie F, Mohammadi H.
    J Cell Physiol; 2019 Jul 01; 234(7):9927-9942. PubMed ID: 30536403
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Landscape of microRNA Targeting in Prostate Cancer Defined by AGO-PAR-CLIP.
    Hamilton MP, Rajapakshe KI, Bader DA, Cerne JZ, Smith EA, Coarfa C, Hartig SM, McGuire SE.
    Neoplasia; 2016 Jun 01; 18(6):356-70. PubMed ID: 27292025
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Roles of microRNAs during prostatic tumorigenesis and tumor progression.
    Fang YX, Gao WQ.
    Oncogene; 2014 Jan 09; 33(2):135-47. PubMed ID: 23455326
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.
    Jackson BL, Grabowska A, Ratan HL.
    BMC Cancer; 2014 Dec 10; 14():930. PubMed ID: 25496077
    [Abstract] [Full Text] [Related]

  • 19. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N.
    J Hum Genet; 2012 Nov 26; 57(11):691-9. PubMed ID: 22854542
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.